Gen Lin
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
-
- Lung Cancer Treatments and Mutations 29
- Brain Metastases and Treatment 4
- Oncology 26
- Cancer Immunotherapy and Biomarkers 9
- Lung Cancer Research Studies 8
- Colorectal Cancer Treatments and Studies 5
- HER2/EGFR in Cancer Research 3
- Co-authors
- Qian Miao (8 shared papers)Zhiyong He (2 shared papers)Kan Jiang (8 shared papers)Yunjian Huang (5 shared papers)Haipeng Xu (6 shared papers)Cheng Huang (4 shared papers)Xiandong Lin (3 shared papers)Weifeng Zhu (2 shared papers)
- Journals
- Annals of Oncology (7 papers)Journal of Thoracic Oncology (7 papers)Translational Lung Cancer Research (3 papers)Therapeutic Advances in Medical Oncology (3 papers)Journal of Neuro-Oncology (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Gen Lin
66 papers receiving 1.1k citations
Gen Lin's Hit Papers
Peers
Comparison fields: 5 of 79
- Oncology 409
- Pulmonary and Respiratory Medicine 372
- Cancer Research 116
- Obstetrics and Gynecology 42
- Immunology 115
Countries citing papers authored by Gen Lin
This map shows the geographic impact of Gen Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gen Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gen Lin more than expected).
Fields of papers citing papers by Gen Lin
This network shows the impact of papers produced by Gen Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gen Lin. The network helps show where Gen Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Gen Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non–Small Cell Lung Cancer Hit paper breakdown → | 2024 | 233 |
| 2 | 2017 | 75 | |
| 3 | ENGOT-en11/GOG-3053/KEYNOTE-B21: a randomised, double-blind, phase III study of pembrolizumab or placebo plus adjuvant chemotherapy with or without radiotherapy in patients with newly diagnosed, high-risk endometrial cancer Hit paper breakdown → | 2024 | 60 |
| 4 | 2017 | 54 | |
| 5 | 2020 | 47 | |
| 6 | 2020 | 42 | |
| 7 | 2013 | 40 | |
| 8 | 2024 | 29 | |
| 9 | 2016 | 28 | |
| 10 | 2022 | 25 | |
| 11 | 2024 | 21 | |
| 12 | 2017 | 20 | |
| 13 | Gu, H. et al. Essential role for Gab2 in the allergic response. Nature 412, 186-190 | 2001 | 19 |
| 14 | 2012 | 17 | |
| 15 | 2021 | 16 | |
| 16 | 2023 | 16 | |
| 17 | 2022 | 15 | |
| 18 | 2022 | 15 | |
| 19 | 2022 | 15 | |
| 20 | 2022 | 15 |
About Gen Lin
Gen Lin is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Neurology and Immunology, having authored 70 papers that have together received 1.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (29 papers), Cancer Immunotherapy and Biomarkers (9 papers), Lung Cancer Research Studies (8 papers), Cancer Genomics and Diagnostics (7 papers), Colorectal Cancer Treatments and Studies (5 papers), Myasthenia Gravis and Thymoma (5 papers), Brain Metastases and Treatment (4 papers) and HER2/EGFR in Cancer Research (3 papers). The work is most often cited by research in Oncology (409 citations), Pulmonary and Respiratory Medicine (372 citations), Cancer Research (116 citations), Obstetrics and Gynecology (42 citations) and Immunology (115 citations). Gen Lin has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Qian Miao, Zhiyong He, Kan Jiang, Yunjian Huang, Haipeng Xu, Cheng Huang, Xiandong Lin, Weifeng Zhu, Yunbin Ye and Dan Hu. Their work appears in journals such as Annals of Oncology, Journal of Thoracic Oncology, Translational Lung Cancer Research, Therapeutic Advances in Medical Oncology and Journal of Neuro-Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.